6185.HK CanSino Biologics Inc

在31/12/2022結束的金融年度: CanSino Biologics Inc的營收decreased by 76.99% ，達到 1.19B。淨利decreased by 148.81%至-1.12B。淨資產decreased by 21.54%到8.38B；每股盈餘從7.74decreased到-4.29。